Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B10 | O60218 | 5/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 5/20 | 1.00 |
| ▸ | TTR | P02766 | 5/20 | 1.00 |
| ▸ | APP | P05067 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | EGFR | P00533 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 1/20 | 1.00 |
| ▸ | ERBB2 | P04626 | 1/20 | 1.00 |
| ▸ | LCK | P06239 | 1/20 | 1.00 |
| ▸ | FYN | P06241 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Caffeic Acid Phenethyl Ester SCHEMBL28294426 | 1.00 | AKR1B10 (1.00) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL93649 | 1.00 | AKR1B10 (1.00) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL30070826 | 1.00 | AKR1B10 (1.00) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL30695557 | 0.99 | TTR (0.97) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL38666014 | 0.96 | TTR (0.93) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| Caffeic Acid Phenethyl Ester SCHEMBL15378852 | 0.95 | APP (0.90) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| SCHEMBL2602741 | 0.92 | APP (0.85) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| SCHEMBL20604716 | 0.91 | APP (0.83) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| SCHEMBL19359013 | 0.90 | APP (0.81) | AKR1B10AKR1B1TTRAPPCYP3A4 | |
| SCHEMBL20604718 | 0.90 | APP (0.81) | AKR1B10AKR1B1TTRAPPCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137644-A1 | COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER | XMK THERAPEUTICS INC. (CA) | 2026-05-21 | — | — | US | claimed |
| WO-2026087695-A1 | TREATMENT FOR METABOLIC DISORDER | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| US-20260091016-A1 | Composition for preventing and/or combating neuroinflammation, particularly in neuropsychiatric and neurological diseases | BEE TERAPI (FR) | 2026-04-02 | — | — | US | claimed |
| EP-4701427-A1 | THERMAL ENERGY SYSTEM FOR ADMINISTERING ACTIVE AGENTS | UltraOral Ltd. (IL) | 2026-03-04 | — | — | EP | claimed |
| WO-2025234960-A1 | BONE TISSUE TREATMENT APPARATUS | UMGE DİŞ MALZEMELERİ VE EKİPMANLARI PAZARLAMA SANAYİ TİCARET LİMİTED ŞİRKETİ (TR) | 2025-11-13 | — | — | WO | claimed |
| EP-4598508-A1 | POLYPHENOLIC SUBSTANCE FORMULATION WITH ANTI-CANCEROGENIC EFFECT | Istanbul Universitesi Rektorlugu (TR) | 2025-08-13 | — | — | EP | claimed |
| CN-119219881-B | Polymer material for preparing tray product, and preparation method and application thereof | 山东一诺威新材料有限公司 | 2025-05-02 | — | — | CN | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-119219881-A | Polymer material for preparing tray product, and preparation method and application thereof | 山东一诺威新材料有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-108181388-A | A kind of method for differentiating willow type propolis and yang gum | 中国农业科学院蜜蜂研究所 | 2018-06-19 | — | — | CN | claimed |
| US-20180117067-A1 | METHODS AND COMPOSITIONS FOR TREATING PANCREATITIS | BAYLOR RESEARCH INSTITUTE | 2018-05-03 | — | — | US | claimed |
| CN-107157978-A | Treat EBV+DLBCL and DLBCL medicine and composition | 中国药科大学 | 2017-09-15 | — | — | CN | claimed |
| CN-106924251-A | A kind of pharmaceutical composition and its application for treating glioma | 中国药科大学 | 2017-07-07 | — | — | CN | claimed |
| WO-2016160880-A1 | METHODS AND COMPOSITIONS FOR TREATING PANCREATITIS | BAYLOR RESEARCH INSTITUTE (US) | 2016-10-06 | — | — | WO | claimed |
| US-20150274633-A2 | PAIN RELIEF COMPOUNDS | UNIVERSITÉ CLERMONT AUVERGNE (FR) | 2015-10-01 | — | — | US | claimed |
| US-20150038466-A1 | PAIN RELIEF COMPOUNDS | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE CLERMONT FERRAND (FR) | 2015-02-05 | — | — | US | claimed |
| CN-101774918-A | Preparation method of cinnamate derivates | UNIV HUAQIAO | 2010-07-14 | — | — | CN | claimed |
| US-20080171004-A1 | Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives | MERCK PATENT GMBH (DE) | 2008-07-17 | — | — | US | claimed |
| CN-101203278-A | Ultraviolet protection | MERCK PATENT GMBH (DE) | 2008-06-18 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171004-A1 | Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives | HPD, HAAO, UGT1A6 | AKR1B10 1257/4885AKR1B1 1345/4885TTR 3973/4885 |
| US-20260091016-A1 | Composition for preventing and/or combating neuroinflammation, particularly in neuropsychiatric and neurological diseases | CNTN1, GAP43, BDNF | AKR1B10 2936/4885AKR1B1 2847/4885TTR 1796/4885 |
| US-20150038466-A1 | PAIN RELIEF COMPOUNDS | OPRL1, OPRK1, TRPV1 | AKR1B10 1601/4885AKR1B1 1390/4885TTR 1663/4885 |
| US-20150274633-A2 | PAIN RELIEF COMPOUNDS | OPRL1, OPRK1, TRPV1 | AKR1B10 1601/4885AKR1B1 1390/4885TTR 1663/4885 |
| US-20260137644-A1 | COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER | TFEB, CUTA, PPARG | AKR1B10 2412/4885AKR1B1 2733/4885TTR 2085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.